Risk of vascular events in patients with polymyalgia rheumatica
- PMID: 25070989
- PMCID: PMC4162802
- DOI: 10.1503/cmaj.140266
Risk of vascular events in patients with polymyalgia rheumatica
Abstract
Background: Polymyalgia rheumatica is one of the most common inflammatory rheumatologic conditions in older adults. Other inflammatory rheumatologic disorders are associated with an excess risk of vascular disease. We investigated whether polymyalgia rheumatica is associated with an increased risk of vascular events.
Methods: We used the General Practice Research Database to identify patients with a diagnosis of incident polymyalgia rheumatica between Jan. 1, 1987, and Dec. 31, 1999. Patients were matched by age, sex and practice with up to 5 patients without polymyalgia rheumatica. Patients were followed until their first vascular event (cardiovascular, cerebrovascular, peripheral vascular) or the end of available records (May 2011). All participants were free of vascular disease before the diagnosis of polymyalgia rheumatica (or matched date). We used Cox regression models to compare time to first vascular event in patients with and without polymyalgia rheumatica.
Results: A total of 3249 patients with polymyalgia rheumatica and 12 735 patients without were included in the final sample. Over a median follow-up period of 7.8 (interquartile range 3.3-12.4) years, the rate of vascular events was higher among patients with polymyalgia rheumatica than among those without (36.1 v. 12.2 per 1000 person-years; adjusted hazard ratio 2.6, 95% confidence interval 2.4-2.9). The increased risk of a vascular event was similar for each vascular disease end point. The magnitude of risk was higher in early disease and in patients younger than 60 years at diagnosis.
Interpretation: Patients with polymyalgia rheumatica have an increased risk of vascular events. This risk is greatest in the youngest age groups. As with other forms of inflammatory arthritis, patients with polymyalgia rheumatica should have their vascular risk factors identified and actively managed to reduce this excess risk.
© 2014 Canadian Medical Association or its licensors.
Figures
Comment in
-
Patients with polymyalgia rheumatica had a 2.6-fold increased risk for vascular events at a median 7.8 y.Ann Intern Med. 2015 Jan 20;162(2):JC12. doi: 10.7326/ACPJC-2015-162-2-012. Ann Intern Med. 2015. PMID: 25599360 No abstract available.
Similar articles
-
Is cancer associated with polymyalgia rheumatica? A cohort study in the General Practice Research Database.Ann Rheum Dis. 2014 Oct;73(10):1769-73. doi: 10.1136/annrheumdis-2013-203465. Epub 2013 Jul 10. Ann Rheum Dis. 2014. PMID: 23842460 Free PMC article.
-
Peripheral arterial disease in polymyalgia rheumatica.Arthritis Res Ther. 2009;11(3):111. doi: 10.1186/ar2685. Epub 2009 May 20. Arthritis Res Ther. 2009. PMID: 19519936 Free PMC article.
-
Incidence of infections associated with oral glucocorticoid dose in people diagnosed with polymyalgia rheumatica or giant cell arteritis: a cohort study in England.CMAJ. 2019 Jun 24;191(25):E680-E688. doi: 10.1503/cmaj.190178. CMAJ. 2019. PMID: 31235489 Free PMC article.
-
[Polymyalgia rheumatica].Orv Hetil. 2006 Sep 17;147(37):1791-802. Orv Hetil. 2006. PMID: 17131799 Review. Hungarian.
-
Polymyalgia rheumatica and risk of coronary artery disease: a systematic review and meta-analysis of observational studies.Rheumatol Int. 2017 Jan;37(1):143-149. doi: 10.1007/s00296-016-3557-5. Epub 2016 Aug 30. Rheumatol Int. 2017. PMID: 27577940 Review.
Cited by
-
Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK Biobank.Rheumatol Adv Pract. 2023 Nov 2;7(3):rkad095. doi: 10.1093/rap/rkad095. eCollection 2023. Rheumatol Adv Pract. 2023. PMID: 38033363 Free PMC article.
-
Serum metabolomic profiling identifies potential biomarkers in arthritis in older adults: an exploratory study.Metabolomics. 2023 Apr 6;19(4):37. doi: 10.1007/s11306-023-02004-y. Metabolomics. 2023. PMID: 37022535 Free PMC article.
-
Burden of atrial fibrillation in patients with rheumatic diseases.World J Clin Cases. 2021 May 16;9(14):3252-3264. doi: 10.12998/wjcc.v9.i14.3252. World J Clin Cases. 2021. PMID: 34002134 Free PMC article.
-
An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica.Sci Rep. 2020 Jul 9;10(1):11407. doi: 10.1038/s41598-020-68215-8. Sci Rep. 2020. PMID: 32647217 Free PMC article.
-
Comorbidities in polymyalgia rheumatica: a systematic review.Arthritis Res Ther. 2018 Nov 20;20(1):258. doi: 10.1186/s13075-018-1757-y. Arthritis Res Ther. 2018. PMID: 30458857 Free PMC article.
References
-
- Avina-Zubieta JA, Thomas J, Sadatsafavi M, et al. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2012;71:1524–9 - PubMed
-
- Roifman I, Beck PL, Anderson TJ, et al. Chronic inflammatory diseases and cardiovascular risk: a systematic review. Can J Cardiol 2011;27:174–82 - PubMed
-
- Bengtsson C, Ohman ML, Nived O, et al. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study. Lupus 2012;21:452–9 - PubMed
-
- Atzeni F, Turiel M, Boccassini L, et al. Cardiovascular involvement in psoriatic arthritis. Reumatismo 2011;63:148–54 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials